Nasrin Dahir

517 total citations
7 papers, 282 citations indexed

About

Nasrin Dahir is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Nasrin Dahir has authored 7 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 5 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Nasrin Dahir's work include Multiple Myeloma Research and Treatments (7 papers), Protein Degradation and Inhibitors (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Nasrin Dahir is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Protein Degradation and Inhibitors (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Nasrin Dahir collaborates with scholars based in United Kingdom, France and United States. Nasrin Dahir's co-authors include Dil Begum, Martin Kaiser, Faith E. Davies, Christopher P. Wardell, Brian A. Walker, Gareth J. Morgan, David C. Johnson, Fiona M. Ross, Eileen M. Boyle and Annamaria Brioli and has published in prestigious journals such as Blood, Genes Chromosomes and Cancer and Blood Cancer Journal.

In The Last Decade

Nasrin Dahir

7 papers receiving 280 citations

Peers

Nasrin Dahir

MB

HEMAT

ONCOL

GENET

PFM

Dil Begum United Kingdom

A. Keith Stewart United States

Scott VanWier United States

Erin Flynt United States

Pamela Hardwick United States

Diane E. Durecki United States

Stephen S.Y. Lam Hong Kong

Laure Buisson France

Mary Ann Yancey United States

Gaetanina Golino Switzerland

Dil Begum United Kingdom

Nasrin Dahir

246 ×1.0

MB

231 ×1.0

HEMAT

92 ×1.0

ONCOL

28 ×1.0

GENET

23 ×1.0

PFM

Citations per year, relative to Nasrin Dahir Nasrin Dahir (= 1×) peers Dil Begum

Countries citing papers authored by Nasrin Dahir

Since Specialization

Citations

This map shows the geographic impact of Nasrin Dahir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nasrin Dahir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nasrin Dahir more than expected).

Fields of papers citing papers by Nasrin Dahir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nasrin Dahir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nasrin Dahir. The network helps show where Nasrin Dahir may publish in the future.

Co-authorship network of co-authors of Nasrin Dahir

This figure shows the co-authorship network connecting the top 25 collaborators of Nasrin Dahir. A scholar is included among the top collaborators of Nasrin Dahir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nasrin Dahir. Nasrin Dahir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Walker, Brian A., Christopher P. Wardell, Annamaria Brioli, et al.. (2014). Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients. Blood Cancer Journal. 4(3). e191–e191. 113 indexed citations

2.

Pawlyn, Charlotte, Lorenzo Melchor, Alex Murison, et al.. (2014). Coexistent hyperdiploidy does not abrogate poor prognosis in myeloma with adverse cytogenetics and may precede IGH translocations. Blood. 125(5). 831–840. 48 indexed citations

3.

Boyle, Eileen M., Paula Proszek, Martin Kaiser, et al.. (2014). A molecular diagnostic approach able to detect the recurrent genetic prognostic factors typical of presenting myeloma. Genes Chromosomes and Cancer. 54(2). 91–98. 17 indexed citations

4.

Pawlyn, Charlotte, Martin Kaiser, Brian A. Walker, et al.. (2014). The Spectrum of Epigenetic Mutations in Myeloma and Their Clinical Impact. Blood. 124(21). 2194–2194. 2 indexed citations

5.

Melchor, Lorenzo, Alexander Murison, Eileen M. Boyle, et al.. (2014). The Extent of Intra-Clonal Genetic Diversity within the Myeloma Clone Is a Predictive Biomarker of Progression and Outcome after Treatment. Blood. 124(21). 640–640. 1 indexed citations

6.

Walker, Brian A., Christopher P. Wardell, David C. Johnson, et al.. (2013). Characterization of IGH locus breakpoints in multiple myeloma indicates a subset of translocations appear to occur in pregerminal center B cells. Blood. 121(17). 3413–3419. 100 indexed citations

7.

Walker, Brian A., Christopher P. Wardell, Dil Begum, et al.. (2013). MYC Translocations In Multiple Myeloma Involve Recruitment Of Enhancer Elements Resulting In Over-Expression and Decreased Overall Survival. Blood. 122(21). 274–274. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact